Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD81 T-cell recall responses

35Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rapid boosting of memory CD8+ T cells (TM) is essential in cancer immunotherapy and the control of certain infectious diseases. However, effector T cells (TE) are a barrier to booster vaccination because they can rapidly kill antigen-bearing antigen-presenting cells (APCs) before TM are engaged. We demonstrate that viral-vectored vaccines delivered by B cells elicit robust TM expansion in the presence of TE, enabling booster immunizations to bypass TE-mediated negative feedback regulation. Our data indicate that viral vector-loaded B cells home to the follicular regions in secondary lymphoid organs, which are anatomically separated from TE and in close proximity to TM. The B cells, however, do not serve as APCs in this area. Rather, classic CD+ dendritic cells serve to stimulate the secondary CD8+ T-cell response. Our data reveal that B cells represent a novel and readily accessible delivery system that can effectively engage secondary CD8+ T-cell activation for prime-boost strategies.

Cite

CITATION STYLE

APA

Zhang, L., Bridle, B. W., Chen, L., Pol, J., Spaner, D., Boudreau, J. E., … Wan, Y. (2013). Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD81 T-cell recall responses. Blood, 121(13), 2432–2439. https://doi.org/10.1182/blood-2012-06-438481

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free